Literature DB >> 11689627

Protective mechanisms induced by a Japanese encephalitis virus DNA vaccine: requirement for antibody but not CD8(+) cytotoxic T-cell responses.

C H Pan1, H W Chen, H W Huang, M H Tao.   

Abstract

We have previously shown that a plasmid (pE) encoding the Japanese encephalitis virus (JEV) envelope (E) protein conferred a high level of protection against a lethal viral challenge. In the present study, we used adoptive transfer experiments and gene knockout mice to demonstrate that the DNA-induced E-specific antibody alone can confer protection in the absence of cytotoxic T-lymphocyte (CTL) functions. Plasmid pE administered by either intramuscular or gene gun injection produced significant E-specific antibodies, helper T (Th)-cell proliferative responses, and CTL activities. Animals receiving suboptimal DNA vaccination produced low titers of anti-E antibodies and were only partially or not protected from viral challenge, indicating a strong correlation between anti-E antibodies and the protective capacity. This observation was confirmed by adoptive transfer experiments. Intravenous transfer of E-specific antisera but not crude or T-cell-enriched immune splenocytes to sublethally irradiated hosts conferred protection against a lethal JEV challenge. Furthermore, experiments with gene knockout mice showed that DNA vaccination did not induce anti-E titers and protective immunity in Igmu(-/-) and I-Abeta(-/-) mice, whereas in CD8alpha(-/-) mice the pE-induced antibody titers and protective rate were comparable to those produced in the wild-type mice. Taken together, these results demonstrate that the anti-E antibody is the most critical protective component in this JEV challenge model and that production of anti-E antibody by pE DNA vaccine is dependent on the presence of CD4(+) T cells but independent of CD8(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689627      PMCID: PMC114732          DOI: 10.1128/JVI.75.23.11457-11463.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Particulate vaccine candidate for Japanese encephalitis induces long-lasting virus-specific memory T lymphocytes in mice.

Authors:  E Konishi; K S Win; I Kurane; P W Mason; R E Shope; F A Ennis
Journal:  Vaccine       Date:  1997-02       Impact factor: 3.641

Review 2.  DNA vaccines.

Authors:  J J Donnelly; J B Ulmer; J W Shiver; M A Liu
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

3.  Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice.

Authors:  E Konishi; I Kurane; P W Mason; R E Shope; F A Ennis
Journal:  Virology       Date:  1997-01-20       Impact factor: 3.616

4.  Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4+ T cells.

Authors:  K Murali-Krishna; V Ravi; R Manjunath
Journal:  J Gen Virol       Date:  1996-04       Impact factor: 3.891

5.  Recognition of nonstructural protein peptides by cytotoxic T lymphocytes raised against Japanese encephalitis virus.

Authors:  K Murali-Krishna; B Ramireddy; V Ravi; R Manjunath
Journal:  Microbiol Immunol       Date:  1995       Impact factor: 1.955

6.  Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection.

Authors:  P W Mason; S Pincus; M J Fournier; T L Mason; R E Shope; E Paoletti
Journal:  Virology       Date:  1991-01       Impact factor: 3.616

7.  Cytotoxic T lymphocytes raised against Japanese encephalitis virus: effector cell phenotype, target specificity and in vitro virus clearance.

Authors:  K Murali-Krishna; V Ravi; R Manjunath
Journal:  J Gen Virol       Date:  1994-04       Impact factor: 3.891

8.  Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes.

Authors:  E Konishi; I Kurane; P W Mason; B L Innis; F A Ennis
Journal:  Am J Trop Med Hyg       Date:  1995-09       Impact factor: 2.345

9.  The flavivirus nonstructural protein NS3 is a dominant source of cytotoxic T cell peptide determinants.

Authors:  M Lobigs; C E Arthur; A Müllbacher; R V Blanden
Journal:  Virology       Date:  1994-07       Impact factor: 3.616

10.  The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice.

Authors:  J J Schlesinger; M Foltzer; S Chapman
Journal:  Virology       Date:  1993-01       Impact factor: 3.616

View more
  17 in total

1.  Genetic vaccination of mice with plasmids encoding the NS1 non-structural protein from tick-borne encephalitis virus and dengue 2 virus.

Authors:  A V Timofeev; V M Butenko; J R Stephenson
Journal:  Virus Genes       Date:  2004-01       Impact factor: 2.332

Review 2.  Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex.

Authors:  Mario Lobigs; Michael S Diamond
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

3.  West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection.

Authors:  James D Brien; Jennifer L Uhrlaub; Janko Nikolich-Zugich
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

4.  CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system.

Authors:  Elizabeth M Sitati; Michael S Diamond
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

5.  A Japanese encephalitis virus peptide present on Johnson grass mosaic virus-like particles induces virus-neutralizing antibodies and protects mice against lethal challenge.

Authors:  Manisha Saini; Sudhanshu Vrati
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

6.  JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody.

Authors:  Maximilian Larena; Natalie A Prow; Roy A Hall; Nikolai Petrovsky; Mario Lobigs
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

7.  The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus.

Authors:  Bimmi Shrestha; Terry Ng; Hsien-Jue Chu; Michelle Noll; Michael S Diamond
Journal:  Vaccine       Date:  2008-02-20       Impact factor: 3.641

Review 8.  Preventive strategies for frequent outbreaks of Japanese encephalitis in Northern India.

Authors:  Vandana Saxena; Tapan N Dhole
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

9.  CD40-CD40 ligand interactions promote trafficking of CD8+ T cells into the brain and protection against West Nile virus encephalitis.

Authors:  Elizabeth Sitati; Erin E McCandless; Robyn S Klein; Michael S Diamond
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

10.  Discovery of common marburgvirus protective epitopes in a BALB/c mouse model.

Authors:  Warren V Kalina; Kelly L Warfield; Gene G Olinger; Sina Bavari
Journal:  Virol J       Date:  2009-08-27       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.